Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman K Thomas

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
The Lancet. Oncology|January 1, 2004
Part II: Hodgkin's lymphoma--diagnosis and treatmentVolker Diehl, Roman K Thomas, Daniel Re
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2012
Epidermal growth factor receptor (EGFR) signaling and covalent EGFR inhibition in lung cancerJohannes M Heuckmann, Daniel Rauh, Roman K Thomas
Blood|February 25, 2005
From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potentialDaniel Re, Roman K Thomas, Karolin Behringer, et al.
The Lancet. Oncology|January 1, 2004
Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cellsRoman K Thomas, Daniel Re, Jürgen Wolf, et al.
Nature Clinical Practice. Oncology|November 3, 2005
Problems and promises of targeted therapy for Hodgkin's lymphomaDaniel Re, Roman K Thomas, Thomas Zander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2017
Resistance Mechanisms to AZD9291 and Rociletinib-ResponseReinhard Büttner, Jürgen Wolf, Roman K Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Expression of signaling mediators downstream of EGF-receptor predict sensitivity to small molecule inhibitors directed against the EGF-receptor pathwayMartin L Sos, Thomas Zander, Roman K Thomas, et al.
British Journal of Haematology|June 17, 2004
Mutational analysis of the IkappaBalpha gene in activated B cell-like diffuse large B-cell lymphomaRoman K Thomas, Claudia Wickenhauser, Samir Tawadros, et al.
Leukemia & Lymphoma|August 5, 2004
Repeated clonal relapses in classical Hodgkin's lymphoma and the occurrence of a clonally unrelated diffuse large B cell non-Hodgkin lymphoma in the same patientRoman K Thomas, Claudia Wickenhauser, Dieter Kube, et al.
Cancer Cell International|February 26, 2020
Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell deathHannah Maria Baumert, Eric Metzger, Matthias Fahrner, et al.
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
The Lancet. Oncology|January 1, 2004
Part II: Hodgkin's lymphoma--diagnosis and treatmentVolker Diehl, Roman K Thomas, Daniel Re
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2012
Epidermal growth factor receptor (EGFR) signaling and covalent EGFR inhibition in lung cancerJohannes M Heuckmann, Daniel Rauh, Roman K Thomas
Blood|February 25, 2005
From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potentialDaniel Re, Roman K Thomas, Karolin Behringer, et al.
The Lancet. Oncology|January 1, 2004
Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cellsRoman K Thomas, Daniel Re, Jürgen Wolf, et al.
Nature Clinical Practice. Oncology|November 3, 2005
Problems and promises of targeted therapy for Hodgkin's lymphomaDaniel Re, Roman K Thomas, Thomas Zander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2017
Resistance Mechanisms to AZD9291 and Rociletinib-ResponseReinhard Büttner, Jürgen Wolf, Roman K Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Expression of signaling mediators downstream of EGF-receptor predict sensitivity to small molecule inhibitors directed against the EGF-receptor pathwayMartin L Sos, Thomas Zander, Roman K Thomas, et al.
British Journal of Haematology|June 17, 2004
Mutational analysis of the IkappaBalpha gene in activated B cell-like diffuse large B-cell lymphomaRoman K Thomas, Claudia Wickenhauser, Samir Tawadros, et al.
Leukemia & Lymphoma|August 5, 2004
Repeated clonal relapses in classical Hodgkin's lymphoma and the occurrence of a clonally unrelated diffuse large B cell non-Hodgkin lymphoma in the same patientRoman K Thomas, Claudia Wickenhauser, Dieter Kube, et al.
Cancer Cell International|February 26, 2020
Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell deathHannah Maria Baumert, Eric Metzger, Matthias Fahrner, et al.
Pageof 14